Senti Biosciences, Inc. - SNTI

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$5.832M
QoQ value delta ($000)
-$2.427M (-29.39%)
Implied price effect (QoQ)
-26.26%
Shares
Total shares
5,614,365
QoQ shares delta
-248,805 (-4.24%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (SNTI)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
NEA Management Company, LLC 3,926 3,775,615 0.2%
Nantahala Capital Management, LLC 923 888,000 0.03%
VANGUARD GROUP INC 653 628,697 0.0%
GEODE CAPITAL MANAGEMENT, LLC 150 144,797 0.0%
Virtu Financial LLC 46 44,409 0.0%
JANE STREET GROUP, LLC 39 38,427 0.0%
MSOP GP, L.L.C. 37 35,737 0.01%
BlackRock, Inc. 24 23,384 0.0%
NORTHERN TRUST CORP 17 16,778 0.0%
STATE STREET CORP 10 10,010 0.0%
UBS Group AG 4 4,529 0.0%
Tower Research Capital LLC (TRC) 3 3,411 0.0%
BANK OF AMERICA CORP /DE/ 0 75 0.0%
MORGAN STANLEY 0 160 0.0%
SBI Securities Co., Ltd. 0 336 0.0%